Sanofi Wins Taxotere Trial Over Hair Loss Claims

Sanofi Wins Taxotere Trial Over Hair Loss Claims



Category: MDL

More Info: Mass Tort Litigation

More than 12,000 individuals have filed lawsuits against Sanofi over claims that the pharmaceutical giant’s breast cancer drug, Taxotere, caused them to develop permanent hair loss. 

Plaintiffs have alleged that had they known about the risk of permanent hair loss, they would have discussed other options with their doctor. The lawsuits also allege that Sanofi was aware that Taxotere could cause permanent hair loss as opposed to temporary hair loss that sometimes occurs with other cancer treatments such as chemotherapy. 

However, juries in the first two bellwether trials, or test cases, have cleared Sanofi of liability. The most recent verdict was returned Nov. 19, 2021 in a New Orleans federal court. In that decision, the jury found that Sanofi provided sufficient warning to a Louisiana woman, Elizabeth Kahn, Reuters reported. 

Taxotere cases have been consolidated in multidistrict litigation (MDL) before U.S. District Judge Jane Triche Milazzo of the Eastern District of Louisiana. Chris Coffin, an attorney representing Kahn, told Reuters in an email, “While disappointed in the result, we are confident that the evidence against Sanofi will result in positive verdicts for plaintiffs around the country in the future.” 

Coffin also indicated that the Kahn decision would be appealed. Kahn sued Sanofi in 2016. She started using Taxotere in 2008. Her complaint alleges that as a result of taking the drug for breast cancer, she has suffered from alopecia

Sanofi is not the only defendant named in the MDL. Since Taxotere also goes by the generic version docetaxel, other manufacturers of the drug as well as distributors are facing litigation for their alleged connection to claims of alopecia. 

Continue reading...

See the original article here: https://medtruth.com/articles/legal-developments/sanofi-wins-taxotere-trial-over-hair-loss-claims/


About TriMark Legal Funding

TriMark Legal Funding was founded in 2003 and is one of America's leading national lawsuit funding companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.

We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as attorney funding and law firm financing for legal practices.

Personal Injury LawsuitsMass Torts

Click here to see the original article.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in a plaintiffs’ legal claim. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for search and marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408